IMAX CEO Richard Gelfond on when the industry could bounce back
Movie theater stocks like IMAX have been struggling amid the pandemic. IMAX stock has been down more than 27%. But could the positive news about Pifzer and BioNTech requesting emergency use authorization from the FDA turn things around for the industry? IMAX CEO Richard Gelfond joins "Squawk Box" to discuss.